Overview

Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer

Status:
Recruiting
Trial end date:
2040-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the effect and side effects of personalized cancer treatment in patients with metastatic colorectal cancer (bowel cancer). All patients included must have metastatic bowel cancer and receive or have received at least two lines of standard chemotherapy. The cancer must not be available for surgery with curative intent.
Phase:
Phase 2
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Cetuximab
Crizotinib
Dasatinib
Everolimus
Gemcitabine
Idelalisib
Methotrexate
Palbociclib
Panobinostat
Pembrolizumab
Talazoparib
Trastuzumab
Venetoclax